Back to Resources

Q2 2026 Diabetes Glucagon Market Preparedness and Access

Market Highlights

  • Amphastar positioned needle-free Baqsimi for severe hypoglycemia preparedness through convenient dosing, savings support, and family-focused campaign.

  • Lupin expanded access to diabetes and chronic disease care.

Questions about this SnapShot or other markets?

U.S. MARKETS

Christine Alongi
alongi@dtwresearch.com

GLOBAL MARKETS

Robin Cefalo
cefalo@dtwresearch.com

SOCIAL MEDIA MARKETS

Andrew Carney
carney@dtwresearch.com

Get in Touch

Want to see what we can do for your organization? We’ll walk you through CDP, train your team, and stay close with ongoing support.

Contact us